Good to see the are still looking at pbt2 for further development.
Also for pbt434:
Benign safety profile in GLP toxicology studies
• Non‐toxic dose exceeds efficacious dose by >10‐fold based on
allometric scaling
Ann: Investor presentation - Biotech Showcase, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $119.6M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $437.3K | 33.91M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 10762260 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 7410666 | 11 |
View Market Depth
| Last trade - 15.33pm 22/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |